60 Degrees Pharmaceuticals Inc. specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases that affect the lives of millions of people.
The company achieved FDA approval of its lead product, ARAKODA® (tafenoquine), for malaria prevention, in 2018. It also collaborates with prominent research organizations in the U.S., Australia, and Singapore.
